Epigenetic deregulation in pediatric acute lymphoblastic leukemia

References

• Bird AP. CpG-rich islands and the function of DNA methylation. Nature 1986; 321:209 - 13; http://dx.doi.org/10.1038/321209a0; PMID: 2423876
   PubMed Web of Science ®Google Scholar
• Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002; 16:6 - 21; http://dx.doi.org/10.1101/gad.947102; PMID: 11782440
   PubMed Web of Science ®Google Scholar
• Mathers JC. Session 2: Personalised nutrition. Epigenomics: a basis for understanding individual differences?. Proc Nutr Soc 2008; 67:390 - 4; http://dx.doi.org/10.1017/S0029665108008744; PMID: 18847515
   PubMed Web of Science ®Google Scholar
• Fang F, Turcan S, Rimner A, Kaufman A, Giri D, Morris LG, Shen R, Seshan V, Mo Q, Heguy A, et al. Breast cancer methylomes establish an epigenomic foundation for metastasis. Sci Transl Med 2011; 3:75ra25; http://dx.doi.org/10.1126/scitranslmed.3001875; PMID: 21430268
   PubMed Web of Science ®Google Scholar
• Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP, Pan F, Pelloski CE, Sulman EP, Bhat KP, et al, Cancer Genome Atlas Research Network. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 2010; 17:510 - 22; http://dx.doi.org/10.1016/j.ccr.2010.03.017; PMID: 20399149
   PubMed Web of Science ®Google Scholar
• Teodoridis JM, Hardie C, Brown R. CpG island methylator phenotype (CIMP) in cancer: causes and implications. Cancer Lett 2008; 268:177 - 86; http://dx.doi.org/10.1016/j.canlet.2008.03.022; PMID: 18471961
   PubMed Web of Science ®Google Scholar
• Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 1999; 96:8681 - 6; http://dx.doi.org/10.1073/pnas.96.15.8681; PMID: 10411935
   PubMed Web of Science ®Google Scholar
• Leone G, Teofili L, Voso MT, Lübbert M. DNA methylation and demethylating drugs in myelodysplastic syndromes and secondary leukemias. Haematologica 2002; 87:1324 - 41; PMID: 12495905
   PubMed Web of Science ®Google Scholar
• Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349:2042 - 54; http://dx.doi.org/10.1056/NEJMra023075; PMID: 14627790
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas N, Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 2012; 490:61 - 70; http://dx.doi.org/10.1038/nature11412; PMID: 23000897
   PubMed Web of Science ®Google Scholar
• Hinoue T, Weisenberger DJ, Lange CP, Shen H, Byun HM, Van Den Berg D, Malik S, Pan F, Noushmehr H, van Dijk CM, et al. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res 2012; 22:271 - 82; http://dx.doi.org/10.1101/gr.117523.110; PMID: 21659424
   PubMed Web of Science ®Google Scholar
• Deneberg S, Guardiola P, Lennartsson A, Qu Y, Gaidzik V, Blanchet O, Karimi M, Bengtzén S, Nahi H, Uggla B, et al. Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks. Blood 2011; 118:5573 - 82; http://dx.doi.org/10.1182/blood-2011-01-332353; PMID: 21960591
   PubMed Web of Science ®Google Scholar
• Baylin SB. Resistance, epigenetics and the cancer ecosystem. Nat Med 2011; 17:288 - 9; http://dx.doi.org/10.1038/nm0311-288; PMID: 21383739
   PubMed Web of Science ®Google Scholar
• Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB, Herman JG. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 2000; 343:1350 - 4; http://dx.doi.org/10.1056/NEJM200011093431901; PMID: 11070098
   PubMed Web of Science ®Google Scholar
• Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005; 352:997 - 1003; http://dx.doi.org/10.1056/NEJMoa043331; PMID: 15758010
   PubMed Web of Science ®Google Scholar
• Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A, Li Y, Bhagwat N, Vasanthakumar A, Fernandez HF, et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 2010; 18:553 - 67; http://dx.doi.org/10.1016/j.ccr.2010.11.015; PMID: 21130701
   PubMed Web of Science ®Google Scholar
• Schuebel KE, Chen W, Cope L, Glöckner SC, Suzuki H, Yi JM, Chan TA, Van Neste L, Van Criekinge W, van den Bosch S, et al. Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet 2007; 3:1709 - 23; http://dx.doi.org/10.1371/journal.pgen.0030157; PMID: 17892325
   PubMed Web of Science ®Google Scholar
• Christman JK. 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene 2002; 21:5483 - 95; http://dx.doi.org/10.1038/sj.onc.1205699; PMID: 12154409
   PubMed Web of Science ®Google Scholar
• Jones PA, Taylor SM. Cellular differentiation, cytidine analogs and DNA methylation. Cell 1980; 20:85 - 93; http://dx.doi.org/10.1016/0092-8674(80)90237-8; PMID: 6156004
   PubMed Web of Science ®Google Scholar
• Wong NC, Ashley D, Chatterton Z, Parkinson-Bates M, Ng HK, Halemba MS, Kowalczyk A, Bedo J, Wang Q, Bell K, et al. A distinct DNA methylation signature defines pediatric pre-B cell acute lymphoblastic leukemia. Epigenetics 2012; 7:535 - 41; http://dx.doi.org/10.4161/epi.20193; PMID: 22531296
   PubMed Web of Science ®Google Scholar
• Davidsson J, Lilljebjörn H, Andersson A, Veerla S, Heldrup J, Behrendtz M, Fioretos T, Johansson B. The DNA methylome of pediatric acute lymphoblastic leukemia. Hum Mol Genet 2009; 18:4054 - 65; http://dx.doi.org/10.1093/hmg/ddp354; PMID: 19679565
   PubMed Web of Science ®Google Scholar
• Figueroa ME, Chen SC, Andersson AK, Phillips LA, Li Y, Sotzen J, Kundu M, Downing JR, Melnick A, Mullighan CG. Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia. J Clin Invest 2013; 123:3099 - 111; http://dx.doi.org/10.1172/JCI66203; PMID: 23921123
   PubMed Web of Science ®Google Scholar
• Nordlund J, Bäcklin CL, Wahlberg P, Busche S, Berglund EC, Eloranta ML, Flaegstad T, Forestier E, Frost BM, Harila-Saari A, et al. Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia. Genome Biol 2013; 14:r105; http://dx.doi.org/10.1186/gb-2013-14-9-r105; PMID: 24063430
   PubMed Web of Science ®Google Scholar
• Sproul D, Kitchen RR, Nestor CE, Dixon JM, Sims AH, Harrison DJ, Ramsahoye BH, Meehan RR. Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns. Genome Biol 2012; 13:R84; http://dx.doi.org/10.1186/gb-2012-13-10-r84; PMID: 23034185
   PubMedGoogle Scholar
• Hogan LE, Meyer JA, Yang J, Wang J, Wong N, Yang W, Condos G, Hunger SP, Raetz E, Saffery R, et al. Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies. Blood 2011; 118:5218 - 26; http://dx.doi.org/10.1182/blood-2011-04-345595; PMID: 21921043
   PubMed Web of Science ®Google Scholar
• Myklebust JH, Josefsen D, Blomhoff HK, Levy FO, Naderi S, Reed JC, Smeland EB. Activation of the cAMP signaling pathway increases apoptosis in human B-precursor cells and is associated with downregulation of Mcl-1 expression. J Cell Physiol 1999; 180:71 - 80; http://dx.doi.org/10.1002/(SICI)1097-4652(199907)180:1<71::AID-JCP8>3.0.CO;2-N; PMID: 10362019
   PubMed Web of Science ®Google Scholar
• Naderi EH, Ugland HK, Diep PP, Josefsen D, Ruud E, Naderi S, Blomhoff HK. Selective inhibition of cell death in malignant vs normal B-cell precursors: implications for cAMP in development and treatment of BCP-ALL. Blood 2013; 121:1805 - 13; http://dx.doi.org/10.1182/blood-2012-08-452698; PMID: 23299313
   PubMed Web of Science ®Google Scholar
• Neves SR, Ram PT, Iyengar R. G protein pathways. Science 2002; 296:1636 - 9; http://dx.doi.org/10.1126/science.1071550; PMID: 12040175
   PubMed Web of Science ®Google Scholar
• Renna M, Jimenez-Sanchez M, Sarkar S, Rubinsztein DC. Chemical inducers of autophagy that enhance the clearance of mutant proteins in neurodegenerative diseases. J Biol Chem 2010; 285:11061 - 7; http://dx.doi.org/10.1074/jbc.R109.072181; PMID: 20147746
   PubMed Web of Science ®Google Scholar
• Pedersen SF, Stock C. Ion channels and transporters in cancer: pathophysiology, regulation, and clinical potential. Cancer Res 2013; 73:1658 - 61; http://dx.doi.org/10.1158/0008-5472.CAN-12-4188; PMID: 23302229
   PubMed Web of Science ®Google Scholar
• Mattson MP, Chan SL. Calcium orchestrates apoptosis. Nat Cell Biol 2003; 5:1041 - 3; http://dx.doi.org/10.1038/ncb1203-1041; PMID: 14647298
   PubMed Web of Science ®Google Scholar
• Bortner CD, Cidlowski JA. Cell shrinkage and monovalent cation fluxes: role in apoptosis. Arch Biochem Biophys 2007; 462:176 - 88; http://dx.doi.org/10.1016/j.abb.2007.01.020; PMID: 17321483
   PubMed Web of Science ®Google Scholar
• García-Cao I, Duran A, Collado M, Carrascosa MJ, Martín-Caballero J, Flores JM, Diaz-Meco MT, Moscat J, Serrano M. Tumour-suppression activity of the proapoptotic regulator Par4. EMBO Rep 2005; 6:577 - 83; http://dx.doi.org/10.1038/sj.embor.7400421; PMID: 15877079
   PubMed Web of Science ®Google Scholar
• Das PM, Thor AD, Edgerton SM, Barry SK, Chen DF, Jones FE. Reactivation of epigenetically silenced HER4/ERBB4 results in apoptosis of breast tumor cells. Oncogene 2010; 29:5214 - 9; http://dx.doi.org/10.1038/onc.2010.271; PMID: 20603612
   PubMed Web of Science ®Google Scholar
• Tsatsanis C, Spandidos DA. The role of oncogenic kinases in human cancer (Review). [Review] Int J Mol Med 2000; 5:583 - 90; PMID: 10812005
   PubMed Web of Science ®Google Scholar
• Quentmeier H, Eberth S, Romani J, Weich HA, Zaborski M, Drexler HG. DNA methylation regulates expression of VEGF-R2 (KDR) and VEGF-R3 (FLT4). BMC Cancer 2012; 12:19; http://dx.doi.org/10.1186/1471-2407-12-19; PMID: 22251800
   PubMed Web of Science ®Google Scholar
• Kober P, Bujko M, Olędzki J, Tysarowski A, Siedlecki JA. Methyl-CpG binding column-based identification of nine genes hypermethylated in colorectal cancer. Mol Carcinog 2011; 50:846 - 56; http://dx.doi.org/10.1002/mc.20763; PMID: 21438024
   PubMed Web of Science ®Google Scholar
• Fu DY, Wang ZM, Wang BL, Chen L, Yang WT, Shen ZZ, Huang W, Shao ZM. Frequent epigenetic inactivation of the receptor tyrosine kinase EphA5 by promoter methylation in human breast cancer. Hum Pathol 2010; 41:48 - 58; http://dx.doi.org/10.1016/j.humpath.2009.06.007; PMID: 19733895
   PubMed Web of Science ®Google Scholar
• Zhang H, Peng C, Hu Y, Li H, Sheng Z, Chen Y, Sullivan C, Cerny J, Hutchinson L, Higgins A, et al. The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells. Nat Genet 2012; 44:861 - 71; http://dx.doi.org/10.1038/ng.2350; PMID: 22797726
   PubMed Web of Science ®Google Scholar
• Favreau AJ, Cross EL, Sathyanarayana P. miR-199b-5p directly targets PODXL and DDR1 and decreased levels of miR-199b-5p correlate with elevated expressions of PODXL and DDR1 in acute myeloid leukemia. Am J Hematol 2012; 87:442 - 6; http://dx.doi.org/10.1002/ajh.23129; PMID: 22374871
   PubMed Web of Science ®Google Scholar
• Touw I, Pouwels K, van Agthoven T, van Gurp R, Budel L, Hoogerbrugge H, Delwel R, Goodwin R, Namen A, Löwenberg B. Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia. Blood 1990; 75:2097 - 101; PMID: 2189505
   PubMed Web of Science ®Google Scholar
• Silva A, Laranjeira AB, Martins LR, Cardoso BA, Demengeot J, Yunes JA, Seddon B, Barata JT. IL-7 contributes to the progression of human T-cell acute lymphoblastic leukemias. Cancer Res 2011; 71:4780 - 9; http://dx.doi.org/10.1158/0008-5472.CAN-10-3606; PMID: 21593192
   PubMed Web of Science ®Google Scholar
• Puel A, Ziegler SF, Buckley RH, Leonard WJ. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet 1998; 20:394 - 7; http://dx.doi.org/10.1038/3877; PMID: 9843216
   PubMed Web of Science ®Google Scholar
• Busche S, Ge B, Vidal R, Spinella JF, Saillour V, Richer C, Healy J, Chen SH, Droit A, Sinnett D, et al. Integration of high-resolution methylome and transcriptome analyses to dissect epigenomic changes in childhood acute lymphoblastic leukemia. Cancer Res 2013; 73:4323 - 36; http://dx.doi.org/10.1158/0008-5472.CAN-12-4367; PMID: 23722552
   PubMed Web of Science ®Google Scholar
• Milani L, Lundmark A, Kiialainen A, Nordlund J, Flaegstad T, Forestier E, Heyman M, Jonmundsson G, Kanerva J, Schmiegelow K, et al. DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia. Blood 2010; 115:1214 - 25; http://dx.doi.org/10.1182/blood-2009-04-214668; PMID: 19965625
   PubMed Web of Science ®Google Scholar
• Nordlund J, Kiialainen A, Karlberg O, Berglund EC, Goransson-Kultima H, Sonderkaer M, Nielsen KL, Gustafsson MG, Behrendtz M, Forestier E, et al. Digital gene expression profiling of primary acute lymphoblastic leukemia cells. Leukemia: official journal of the Leukemia Society of America. Leukemia Research Fund, UK 2012; 26:1218 - 27; http://dx.doi.org/10.1038/leu.2011.358
   PubMed Web of Science ®Google Scholar
• Zelent A, Greaves M, Enver T. Role of the TEL-AML1 fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemia. Oncogene 2004; 23:4275 - 83; http://dx.doi.org/10.1038/sj.onc.1207672; PMID: 15156184
   PubMed Web of Science ®Google Scholar
• Pui CH, Carroll WL, Meshinchi S, Arceci RJ. Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol 2011; 29:551 - 65; http://dx.doi.org/10.1200/JCO.2010.30.7405; PMID: 21220611
   PubMed Web of Science ®Google Scholar
• Torrano V, Procter J, Cardus P, Greaves M, Ford AM. ETV6-RUNX1 promotes survival of early B lineage progenitor cells via a dysregulated erythropoietin receptor. Blood 2011; 118:4910 - 8; http://dx.doi.org/10.1182/blood-2011-05-354266; PMID: 21900195
   PubMed Web of Science ®Google Scholar
• Fine BM, Stanulla M, Schrappe M, Ho M, Viehmann S, Harbott J, Boxer LM. Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia. Blood 2004; 103:1043 - 9; http://dx.doi.org/10.1182/blood-2003-05-1518; PMID: 14525776
   PubMed Web of Science ®Google Scholar
• Li BS, Gu LJ, Luo CY, Li WS, Jiang LM, Shen SH, Jiang H, Shen SH, Zhang B, Chen J, et al. The downregulation of asparagine synthetase expression can increase the sensitivity of cells resistant to l-asparaginase. Leukemia: official journal of the Leukemia Society of America. Leukemia Research Fund, UK 2006; 20:2199 - 201; http://dx.doi.org/10.1038/sj.leu.2404423
   PubMed Web of Science ®Google Scholar
• Ramakers-van Woerden NL, Pieters R, Loonen AH, Hubeek I, van Drunen E, Beverloo HB, Slater RM, Harbott J, Seyfarth J, van Wering ER, et al. TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia. Blood 2000; 96:1094 - 9; PMID: 10910927
   PubMed Web of Science ®Google Scholar
• Vrooman LM, Stevenson KE, Supko JG, O’Brien J, Dahlberg SE, Asselin BL, Athale UH, Clavell LA, Kelly KM, Kutok JL, et al. Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institute ALL Consortium Protocol 00-01. J Clin Oncol 2013; 31:1202 - 10; http://dx.doi.org/10.1200/JCO.2012.43.2070; PMID: 23358966
   PubMed Web of Science ®Google Scholar
• Naor D, Nedvetzki S, Golan I, Melnik L, Faitelson Y. CD44 in cancer. Crit Rev Clin Lab Sci 2002; 39:527 - 79; http://dx.doi.org/10.1080/10408360290795574; PMID: 12484499
   PubMed Web of Science ®Google Scholar
• Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R, Behm FG, Raimondi SC, Relling MV, Patel A, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002; 1:133 - 43; http://dx.doi.org/10.1016/S1535-6108(02)00032-6; PMID: 12086872
   PubMed Web of Science ®Google Scholar
• Liu J, Jiang G. CD44 and hematologic malignancies. Cell Mol Immunol 2006; 3:359 - 65; PMID: 17092433
   PubMed Web of Science ®Google Scholar
• Paulsson K, Johansson B. High hyperdiploid childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer 2009; 48:637 - 60; http://dx.doi.org/10.1002/gcc.20671; PMID: 19415723
   PubMed Web of Science ®Google Scholar
• Zheng S, Ma X, Zhang L, Gunn L, Smith MT, Wiemels JL, Leung K, Buffler PA, Wiencke JK. Hypermethylation of the 5′ CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemia. Cancer Res 2004; 64:2000 - 6; http://dx.doi.org/10.1158/0008-5472.CAN-03-2387; PMID: 15026336
   PubMed Web of Science ®Google Scholar
• Della Peruta M, Martinelli G, Moratti E, Pintani D, Vezzalini M, Mafficini A, Grafone T, Iacobucci I, Soverini S, Murineddu M, et al. Protein tyrosine phosphatase receptor type gamma is a functional tumor suppressor gene specifically downregulated in chronic myeloid leukemia. Cancer Res 2010; 70:8896 - 906; http://dx.doi.org/10.1158/0008-5472.CAN-10-0258; PMID: 20959494
   PubMed Web of Science ®Google Scholar
• Dutta C, Day T, Kopp N, van Bodegom D, Davids MS, Ryan J, Bird L, Kommajosyula N, Weigert O, Yoda A, et al. BCL2 suppresses PARP1 function and nonapoptotic cell death. Cancer Res 2012; 72:4193 - 203; http://dx.doi.org/10.1158/0008-5472.CAN-11-4204; PMID: 22689920
   PubMed Web of Science ®Google Scholar
• Andersson A, Edén P, Olofsson T, Fioretos T. Gene expression signatures in childhood acute leukemias are largely unique and distinct from those of normal tissues and other malignancies. BMC Med Genomics 2010; 3:6; http://dx.doi.org/10.1186/1755-8794-3-6; PMID: 20211010
   PubMed Web of Science ®Google Scholar
• Du P, Kibbe WA, Lin SM. lumi: a pipeline for processing Illumina microarray. Bioinformatics 2008; 24:1547 - 8; http://dx.doi.org/10.1093/bioinformatics/btn224; PMID: 18467348
   PubMed Web of Science ®Google Scholar
• Smyth GK. Limma: linear models for microarray data. New York: Springer, 2005.
   Google Scholar
• Triche T Jr. IlluminaHumanMethylation450k.db: Illumina Human Methylation 450k annotation data. R package version 1.4.7. Bioconductor; 2012.
   Google Scholar
• Tong WH, Pieters R, Hop WC, Lanvers-Kaminsky C, Boos J, van der Sluis IM. No evidence of increased asparagine levels in the bone marrow of patients with acute lymphoblastic leukemia during asparaginase therapy. Pediatr Blood Cancer 2013; 60:258 - 61; http://dx.doi.org/10.1002/pbc.24292; PMID: 22961784
   PubMed Web of Science ®Google Scholar